Global Neuroprotection Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Neuroprotection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 27970 million by 2025, from USD 23650 million in 2019.
The Neuroprotection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neuroprotection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neuroprotection market has been segmented into:
Free Anti-Inflammatory Agents
Radical Trapping Agents (Antioxidants)
Apoptosis Inhibitors
Glutamate Antagonists (Anti-Excitotoxic Agents)
Neurotrophic Factors (NTFs)
Stimulants
Metal Ion Chelators
Other Products
By Application, Neuroprotection has been segmented into:
Prevention
Treatment
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuroprotection market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuroprotection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuroprotection market.
The report offers in-depth assessment of the growth and other aspects of the Neuroprotection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Neuroprotection Market Share Analysis
Neuroprotection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuroprotection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuroprotection sales, revenue and market share for each player covered in this report.
The major players covered in Neuroprotection are:
F. Hoffmann-La Roche
Astrocyte Pharmaceuticals
Allergan
Eli Lilly and Company
Dr. Reddy's Laboratories
Daiichi Sankyo Company
Biogen
AstraZeneca
Novartis
Teva Pharmaceutical Industries
Table of Contents
1 Neuroprotection Market Overview
1.1 Product Overview and Scope of Neuroprotection
1.2 Classification of Neuroprotection by Type
1.2.1 Global Neuroprotection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Neuroprotection Revenue Market Share by Type in 2019
1.2.3 Free Anti-Inflammatory Agents
1.2.4 Radical Trapping Agents (Antioxidants)
1.2.5 Apoptosis Inhibitors
1.2.6 Glutamate Antagonists (Anti-Excitotoxic Agents)
1.2.7 Neurotrophic Factors (NTFs)
1.2.8 Stimulants
1.2.9 Metal Ion Chelators
1.2.10 Other Products
1.3 Global Neuroprotection Market by Application
1.3.1 Overview: Global Neuroprotection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prevention
1.3.3 Treatment
1.4 Global Neuroprotection Market by Regions
1.4.1 Global Neuroprotection Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Neuroprotection (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Neuroprotection Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Neuroprotection Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroprotection Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Neuroprotection Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroprotection Status and Prospect (2015-2025)
2 Company Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffmann-La Roche SWOT Analysis
2.1.4 F. Hoffmann-La Roche Product and Services
2.1.5 F. Hoffmann-La Roche Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.2 Astrocyte Pharmaceuticals
2.2.1 Astrocyte Pharmaceuticals Details
2.2.2 Astrocyte Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Astrocyte Pharmaceuticals SWOT Analysis
2.2.4 Astrocyte Pharmaceuticals Product and Services
2.2.5 Astrocyte Pharmaceuticals Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Allergan SWOT Analysis
2.3.4 Allergan Product and Services
2.3.5 Allergan Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly and Company SWOT Analysis
2.4.4 Eli Lilly and Company Product and Services
2.4.5 Eli Lilly and Company Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dr. Reddy's Laboratories
2.5.1 Dr. Reddy's Laboratories Details
2.5.2 Dr. Reddy's Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Dr. Reddy's Laboratories SWOT Analysis
2.5.4 Dr. Reddy's Laboratories Product and Services
2.5.5 Dr. Reddy's Laboratories Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.6 Daiichi Sankyo Company
2.6.1 Daiichi Sankyo Company Details
2.6.2 Daiichi Sankyo Company Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Daiichi Sankyo Company SWOT Analysis
2.6.4 Daiichi Sankyo Company Product and Services
2.6.5 Daiichi Sankyo Company Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biogen SWOT Analysis
2.7.4 Biogen Product and Services
2.7.5 Biogen Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Teva Pharmaceutical Industries SWOT Analysis
2.10.4 Teva Pharmaceutical Industries Product and Services
2.10.5 Teva Pharmaceutical Industries Neuroprotection Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Neuroprotection Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroprotection Players Market Share
3.2.2 Top 10 Neuroprotection Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Neuroprotection Revenue and Market Share by Regions
4.2 North America Neuroprotection Revenue and Growth Rate (2015-2020)
4.3 Europe Neuroprotection Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuroprotection Revenue and Growth Rate (2015-2020)
4.5 South America Neuroprotection Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Neuroprotection Revenue and Growth Rate (2015-2020)
5 North America Neuroprotection Revenue by Countries
5.1 North America Neuroprotection Revenue by Countries (2015-2020)
5.2 USA Neuroprotection Revenue and Growth Rate (2015-2020)
5.3 Canada Neuroprotection Revenue and Growth Rate (2015-2020)
5.4 Mexico Neuroprotection Revenue and Growth Rate (2015-2020)
6 Europe Neuroprotection Revenue by Countries
6.1 Europe Neuroprotection Revenue by Countries (2015-2020)
6.2 Germany Neuroprotection Revenue and Growth Rate (2015-2020)
6.3 UK Neuroprotection Revenue and Growth Rate (2015-2020)
6.4 France Neuroprotection Revenue and Growth Rate (2015-2020)
6.5 Russia Neuroprotection Revenue and Growth Rate (2015-2020)
6.6 Italy Neuroprotection Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Neuroprotection Revenue by Countries
7.1 Asia-Pacific Neuroprotection Revenue by Countries (2015-2020)
7.2 China Neuroprotection Revenue and Growth Rate (2015-2020)
7.3 Japan Neuroprotection Revenue and Growth Rate (2015-2020)
7.4 Korea Neuroprotection Revenue and Growth Rate (2015-2020)
7.5 India Neuroprotection Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Neuroprotection Revenue and Growth Rate (2015-2020)
8 South America Neuroprotection Revenue by Countries
8.1 South America Neuroprotection Revenue by Countries (2015-2020)
8.2 Brazil Neuroprotection Revenue and Growth Rate (2015-2020)
8.3 Argentina Neuroprotection Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Neuroprotection by Countries
9.1 Middle East & Africa Neuroprotection Revenue by Countries (2015-2020)
9.2 Saudi Arabia Neuroprotection Revenue and Growth Rate (2015-2020)
9.3 UAE Neuroprotection Revenue and Growth Rate (2015-2020)
9.4 Egypt Neuroprotection Revenue and Growth Rate (2015-2020)
9.5 South Africa Neuroprotection Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Neuroprotection Revenue and Market Share by Type (2015-2020)
10.2 Global Neuroprotection Market Forecast by Type (2019-2024)
10.3 Free Anti-Inflammatory Agents Revenue Growth Rate (2015-2025)
10.4 Radical Trapping Agents (Antioxidants) Revenue Growth Rate (2015-2025)
10.5 Apoptosis Inhibitors Revenue Growth Rate (2015-2025)
10.6 Glutamate Antagonists (Anti-Excitotoxic Agents) Revenue Growth Rate (2015-2025)
10.7 Neurotrophic Factors (NTFs) Revenue Growth Rate (2015-2025)
10.8 Stimulants Revenue Growth Rate (2015-2025)
10.9 Metal Ion Chelators Revenue Growth Rate (2015-2025)
10.10 Other Products Revenue Growth Rate (2015-2025)
11 Global Neuroprotection Market Segment by Application
11.1 Global Neuroprotection Revenue Market Share by Application (2015-2020)
11.2 Neuroprotection Market Forecast by Application (2019-2024)
11.3 Prevention Revenue Growth (2015-2020)
11.4 Treatment Revenue Growth (2015-2020)
12 Global Neuroprotection Market Size Forecast (2021-2025)
12.1 Global Neuroprotection Market Size Forecast (2021-2025)
12.2 Global Neuroprotection Market Forecast by Regions (2021-2025)
12.3 North America Neuroprotection Revenue Market Forecast (2021-2025)
12.4 Europe Neuroprotection Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Neuroprotection Revenue Market Forecast (2021-2025)
12.6 South America Neuroprotection Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Neuroprotection Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Neuroprotection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuroprotection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuroprotection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Neuroprotection Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 6. F. Hoffmann-La Roche Neuroprotection Major Business
Table 7. F. Hoffmann-La Roche Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 8. F. Hoffmann-La Roche SWOT Analysis
Table 9. F. Hoffmann-La Roche Neuroprotection Product and Solutions
Table 10. F. Hoffmann-La Roche Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Astrocyte Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Astrocyte Pharmaceuticals Neuroprotection Major Business
Table 13. Astrocyte Pharmaceuticals Neuroprotection Total Revenue (USD Million) (2018-2019)
Table 14. Astrocyte Pharmaceuticals SWOT Analysis
Table 15. Astrocyte Pharmaceuticals Neuroprotection Product and Solutions
Table 16. Astrocyte Pharmaceuticals Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Allergan Corporate Information, Location and Competitors
Table 18. Allergan Neuroprotection Major Business
Table 19. Allergan Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 20. Allergan SWOT Analysis
Table 21. Allergan Neuroprotection Product and Solutions
Table 22. Allergan Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Eli Lilly and Company Corporate Information, Location and Competitors
Table 24. Eli Lilly and Company Neuroprotection Major Business
Table 25. Eli Lilly and Company Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 26. Eli Lilly and Company SWOT Analysis
Table 27. Eli Lilly and Company Neuroprotection Product and Solutions
Table 28. Eli Lilly and Company Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Dr. Reddy's Laboratories Corporate Information, Location and Competitors
Table 30. Dr. Reddy's Laboratories Neuroprotection Major Business
Table 31. Dr. Reddy's Laboratories Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 32. Dr. Reddy's Laboratories SWOT Analysis
Table 33. Dr. Reddy's Laboratories Neuroprotection Product and Solutions
Table 34. Dr. Reddy's Laboratories Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Daiichi Sankyo Company Corporate Information, Location and Competitors
Table 36. Daiichi Sankyo Company Neuroprotection Major Business
Table 37. Daiichi Sankyo Company Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 38. Daiichi Sankyo Company SWOT Analysis
Table 39. Daiichi Sankyo Company Neuroprotection Product and Solutions
Table 40. Daiichi Sankyo Company Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Biogen Corporate Information, Location and Competitors
Table 42. Biogen Neuroprotection Major Business
Table 43. Biogen Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 44. Biogen SWOT Analysis
Table 45. Biogen Neuroprotection Product and Solutions
Table 46. Biogen Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AstraZeneca Corporate Information, Location and Competitors
Table 48. AstraZeneca Neuroprotection Major Business
Table 49. AstraZeneca Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 50. AstraZeneca SWOT Analysis
Table 51. AstraZeneca Neuroprotection Product and Solutions
Table 52. AstraZeneca Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Novartis Corporate Information, Location and Competitors
Table 54. Novartis Neuroprotection Major Business
Table 55. Novartis Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 56. Novartis SWOT Analysis
Table 57. Novartis Neuroprotection Product and Solutions
Table 58. Novartis Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 60. Teva Pharmaceutical Industries Neuroprotection Major Business
Table 61. Teva Pharmaceutical Industries Neuroprotection Total Revenue (USD Million) (2017-2018)
Table 62. Teva Pharmaceutical Industries SWOT Analysis
Table 63. Teva Pharmaceutical Industries Neuroprotection Product and Solutions
Table 64. Teva Pharmaceutical Industries Neuroprotection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Neuroprotection Revenue (Million USD) by Players (2015-2020)
Table 66. Global Neuroprotection Revenue Share by Players (2015-2020)
Table 67. Global Neuroprotection Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Neuroprotection Revenue Market Share by Regions (2015-2020)
Table 69. North America Neuroprotection Revenue by Countries (2015-2020)
Table 70. North America Neuroprotection Revenue Market Share by Countries (2015-2020)
Table 71. Europe Neuroprotection Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Neuroprotection Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Neuroprotection Revenue by Countries (2015-2020)
Table 74. South America Neuroprotection Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Neuroprotection Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Neuroprotection Revenue Market Share by Countries (2015-2020)
Table 77. Global Neuroprotection Revenue (Million USD) by Type (2015-2020)
Table 78. Global Neuroprotection Revenue Share by Type (2015-2020)
Table 79. Global Neuroprotection Revenue Forecast by Type (2021-2025)
Table 80. Global Neuroprotection Revenue by Application (2015-2020)
Table 81. Global Neuroprotection Revenue Share by Application (2015-2020)
Table 82. Global Neuroprotection Revenue Forecast by Application (2021-2025)
Table 83. Global Neuroprotection Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Neuroprotection Picture
Figure 2. Global Neuroprotection Revenue Market Share by Type in 2019
Figure 3. Free Anti-Inflammatory Agents Picture
Figure 4. Radical Trapping Agents (Antioxidants) Picture
Figure 5. Apoptosis Inhibitors Picture
Figure 6. Glutamate Antagonists (Anti-Excitotoxic Agents) Picture
Figure 7. Neurotrophic Factors (NTFs) Picture
Figure 8. Stimulants Picture
Figure 9. Metal Ion Chelators Picture
Figure 10. Other Products Picture
Figure 11. Neuroprotection Revenue Market Share by Application in 2019
Figure 12. Prevention Picture
Figure 13. Treatment Picture
Figure 14. Global Neuroprotection Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Neuroprotection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Neuroprotection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Neuroprotection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Neuroprotection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Neuroprotection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Neuroprotection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Neuroprotection Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Neuroprotection Revenue Market Share in 2019
Figure 23. Global Top 10 Players Neuroprotection Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Neuroprotection Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Neuroprotection Revenue Market Share by Regions (2015-2020)
Figure 27. Global Neuroprotection Revenue Market Share by Regions in 2018
Figure 28. North America Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 29. Europe Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 31. South America Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 33. North America Neuroprotection Revenue Market Share by Countries (2015-2020)
Figure 34. North America Neuroprotection Revenue Market Share by Countries in 2019
Figure 35. USA Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 36. Canada Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 38. Europe Neuroprotection Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Neuroprotection Revenue Market Share by Countries in 2019
Figure 40. Germany Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 41. UK Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 42. France Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 43. Russia Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 44. Italy Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Neuroprotection Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Neuroprotection Revenue Market Share by Countries in 2019
Figure 47. China Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 48. Japan Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 49. Korea Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 50. India Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 52. South America Neuroprotection Revenue Market Share by Countries (2015-2020)
Figure 53. South America Neuroprotection Revenue Market Share by Countries in 2019
Figure 54. Brazil Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Neuroprotection Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Neuroprotection Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 59. UAE Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Neuroprotection Revenue and Growth Rate (2015-2020)
Figure 62. Global Neuroprotection Revenue Share by Type (2015-2020)
Figure 63. Global Neuroprotection Revenue Share by Type in 2019
Figure 64. Global Neuroprotection Market Share Forecast by Type (2021-2025)
Figure 65. Global Free Anti-Inflammatory Agents Revenue Growth Rate (2015-2020)
Figure 66. Global Radical Trapping Agents (Antioxidants) Revenue Growth Rate (2015-2020)
Figure 67. Global Apoptosis Inhibitors Revenue Growth Rate (2015-2020)
Figure 68. Global Glutamate Antagonists (Anti-Excitotoxic Agents) Revenue Growth Rate (2015-2020)
Figure 69. Global Neurotrophic Factors (NTFs) Revenue Growth Rate (2015-2020)
Figure 70. Global Stimulants Revenue Growth Rate (2015-2020)
Figure 71. Global Metal Ion Chelators Revenue Growth Rate (2015-2020)
Figure 72. Global Other Products Revenue Growth Rate (2015-2020)
Figure 73. Global Neuroprotection Revenue Share by Application (2015-2020)
Figure 74. Global Neuroprotection Revenue Share by Application in 2019
Figure 75. Global Neuroprotection Market Share Forecast by Application (2021-2025)
Figure 76. Global Prevention Revenue Growth Rate (2015-2020)
Figure 77. Global Treatment Revenue Growth Rate (2015-2020)
Figure 78. Global Neuroprotection Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Neuroprotection Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Neuroprotection Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Neuroprotection Revenue Market Forecast (2021-2025)
Figure 82. Europe Neuroprotection Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Neuroprotection Revenue Market Forecast (2021-2025)
Figure 84. South America Neuroprotection Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Neuroprotection Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
F. Hoffmann-La Roche
Astrocyte Pharmaceuticals
Allergan
Eli Lilly and Company
Dr. Reddy's Laboratories
Daiichi Sankyo Company
Biogen
AstraZeneca
Novartis
Teva Pharmaceutical Industries
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets